SELCIA LTD has a total of 17 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United Kingdom, Canada and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are WYETH HOLDINGS CO, CURIS INC and DAJITI SANKIO KOMPANI LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 8 | |
#2 | Canada | 3 | |
#3 | United States | 3 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Environmental technology | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Medical preparations | |
#5 | Climate change adaptation technologies | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Highton Adrian John | 5 |
#2 | Steadman Victoria Alexandra | 5 |
#3 | Siegel Dustin Scott | 5 |
#4 | Jansa Petr | 5 |
#5 | Lazarides Linos | 5 |
#6 | Keats Andrew John | 5 |
#7 | Poullennec Karine G | 5 |
#8 | Dean David Kenneth | 5 |
#9 | Schrier Adam James | 5 |
#10 | Aciro Caroline | 5 |
Publication | Filing date | Title |
---|---|---|
GB201301842D0 | Beta-Lactam Compounds | |
GB201121042D0 | Beta-lactam compounds | |
WO2011036476A1 | Affinity capillary electrophoresis method for assessing a biological interraction of a ligand/receptor pair such as g protein coupled receptor and its targets as well as for drug screening | |
GB201006496D0 | Screening method | |
GB0916636D0 | Screening method | |
GB0816759D0 | Compounds | |
GB0809333D0 | Medical uses | |
GB0717790D0 | Compounds |